Venus Remedies Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Venus Remedies has received marketing authorisation in Indonesia for its antibiotic combination Ceftazidime + Avibactam, granted by the relevant Indonesian drug regulatory authority. This approval marks the first marketing authorisation for Ceftazidime + Avibactam for the Company in Indonesia.

The product is indicated for the treatment of serious infections caused by multi-drug resistant gram-negative pathogens, including complicated intra-abdominal infections and complicated urinary tract infections

Powered by Capital Market - Live News

Zuari Industries Ltd, Vipul Ltd, Orient Ceratech Ltd and Urban Company Ltd are among the other gainers in the BSE's 'B' group today, 11 November 2025.

Venus Remedies Ltd spiked 14.69% to Rs 538 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 27045 shares were traded on the counter so far as against the average daily volumes of 1651 shares in the past one month.

Zuari Industries Ltd soared 12.02% to Rs 343. The stock was the second biggest gainer in 'B' group. On the BSE, 66349 shares were traded on the counter so far as against the average daily volumes of 13731 shares in the past one month.

Vipul Ltd surged 9.89% to Rs 9.33. The stock was the third biggest gainer in 'B' group. On the BSE, 30899 shares were traded on the counter so far as against the average daily volumes of 64353 shares in the past one month.

Orient Ceratech Ltd added 9.71% to Rs 39.09. The stock was the fourth biggest gainer in 'B' group. On the BSE, 54188 shares were traded on the counter so far as against the average daily volumes of 5194 shares in the past one month.

Urban Company Ltd jumped 8.11% to Rs 143.95. The stock was the fifth biggest gainer in 'B' group. On the BSE, 11.44 lakh shares were traded on the counter so far as against the average daily volumes of 6.48 lakh shares in the past one month.

Powered by Capital Market - Live News

Net profit of Venus Remedies rose 473.50% to Rs 20.13 crore in the quarter ended September 2025 as against Rs 3.51 crore during the previous quarter ended September 2024. Sales rose 13.32% to Rs 192.75 crore in the quarter ended September 2025 as against Rs 170.10 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Venus Remedies will hold a meeting of the Board of Directors of the Company on 10 November 2025.

Powered by Capital Market - Live News